The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia.

Giovanni Del Poeta; Maria Ilaria Del Principe; Maria Antonietta Irno Consalvo; Luca Maurillo; Francesco Buccisano; Adriano Venditti; Carla Mazzone; Antonio Bruno; Laura Gianní; Giovanni Capelli

doi:10.1002/cncr.21535

The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia.

Identifier:nobleid.org/w1/20260515/4DCC1AC4

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/4DCC1AC4.svg?ark=w1%2F20260515%2F4DCC1AC4)](https://nobleid.org/work/w1/20260515/4DCC1AC4)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Giovanni Del Poeta

Maria Ilaria Del Principe

Maria Antonietta Irno Consalvo

Claim authorship of this work

The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia.

Identifier:nobleid.org/w1/20260515/4DCC1AC4

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/4DCC1AC4.svg?ark=w1%2F20260515%2F4DCC1AC4)](https://nobleid.org/work/w1/20260515/4DCC1AC4)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Giovanni Del Poeta

Maria Ilaria Del Principe

Maria Antonietta Irno Consalvo

Claim authorship of this work